Taiwan

Principal investigator:

Jane Chang
Mind-Body Interface Research Center

Dr. Chang’s main research interests include the search for novel treatments and biomarkers for depression and attention deficit hyperactivity disorder (ADHD), with a special focus on omega-3 polyunsaturated fatty acids.

Study group:

Kai-Jie Yang

Ayesha Zafar Iqbal

Publications:

Chang JP,* Su KP, Mondelli V, Pariante CM. Cortisol and Inflammatory Biomarker Levels in Youths with Attention Deficit Hyperactivity Disorder (ADHD): Evidence from a Systematic Review with Meta-analysis. Translational Psychiatry. 2021;19:430. (Corresponding author).

Chang JP, Su KP, Mondelli V, Satyanarayanan SK, Yang HT, Chiang YJ, Chen HT, Pariante CM. High-dose eicosapentaenoic acid (EPA) improves attention and vigilance in children and adolescents with attention deficit hyperactivity disorder (ADHD) and low endogenous EPA levels. Translational Psychiatry. 2019; 9:303.

Chang JP, Su KP, Mondelli V, Pariante CM. Omega-3 Polyunsaturated Fatty Acids in Youths with Attention Deficit Hyperactivity Disorder (ADHD): A Systematic Review and Meta-Analysis of Clinical Trials and Biological Studies. Neuropsychopharmacology. 2018, 43:534-545. (Corresponding author).

Chang JP, Mondelli V, Satyanarayanan SK, Chiang YJ, Chen HT, Su KP, Pariante CM. Cortisol, inflammatory biomarkers and neutrophins in children and adolescents with attention deficit hyperactivity disorder (ADHD) in Taiwan. Brain, Behavior and Immunity. 2020;88:105-113.

Chang JP, Chang SS, Yang HT, Chen HT, Chien YC, Yang B, Su H, Su KP. Omega-3 polyunsaturated fatty acids in cadiovascular diseases comorbid major depressive diosrder-Results from a randomized controlled trial. Brain Behavior and Immunity. 2020;85:14-20.